Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques
Open Access
- 23 June 2009
- journal article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 9 (1) , 27
Abstract
Background: Myeloperoxidase (MPO) -containing macrophages and neutrophils have been described at sites of plaque rupture. The presence of these cells in precursor lesions to acute rupture (thin cap atheroma, or vulnerable plaque) and within thrombi adjacent to ruptures has not been described, nor an association with iron-containing macrophages within unstable plaques. Methods: We studied 61 acute ruptures, 15 organizing ruptures, 31 thin cap fibroatheromas, and 28 fibroatheromas from 72 sudden coronary death victims by immunohistochemical and histochemical techniques. Inflammatory cells were typed with anti-CD68 (macrophages), anti-BP-30 (neutrophil bactericidal glycoprotein), and anti-MPO. Iron was localized by Mallory's Prussian blue stain. In selected plaques alpha smooth muscle actin (DAKO, Carpinteria, CA, clone M0851) was performed. Results: MPO positive cells were present in 79% of ruptured caps, 28% of thin cap fibroatheroma, and no fibroatheromas; neutrophils were present in 72% of ruptures, 8% of thin cap fibroatheromas, and no fibroatheromas. Iron containing foam cells were present in the caps of 93% of acute ruptures, of 85% of organizing ruptures, 20% of thin cap atheromas, and 10% of fibroatheromas. MPO positive cells were more frequent in occlusive than non-occlusive thrombi adjacent to ruptures (p = .006) and were more numerous in diabetics compared to non-diabetics (p = .002) Conclusion: Unstable fibrous caps are more likely to contain MPO-positive cells, neutrophils, and iron-containing macrophages than fibrous caps of stable fibroatheromas. MPO-positive cells in thrombi adjacent to disrupted plaques are associated with occlusive thrombi and are more numerous in diabetic patients.Keywords
This publication has 30 references indexed in Scilit:
- Mieloperoxidase e doença arterial coronariana: da pesquisa à prática clínicaArquivos Brasileiros de Cardiologia, 2008
- Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary SyndromesMediators of Inflammation, 2008
- Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy IndividualsJACC, 2007
- Myeloperoxidase and Plaque VulnerabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Macrophage Myeloperoxidase Regulation by Granulocyte Macrophage Colony-Stimulating Factor in Human Atherosclerosis and Implications in Acute Coronary SyndromesThe American Journal of Pathology, 2001
- Consequences of Total and Subtotal Myeloperoxidase Deficiency: Risk or Benefit ?Acta Haematologica, 2000
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994
- Coronary thrombosis: Pathogenesis and clinical manifestationsThe American Journal of Cardiology, 1991
- Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromesThe American Journal of Cardiology, 1989
- Therapeutic efficacy and safety of oral propafenone for atrial fibrillationThe American Journal of Cardiology, 1989